Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013Antonella d'Arminio Monforte, Laura Galli, Sergio Lo Caputo, et al.
Psychopharmacology|March 13, 2003
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET studyCristina Messa, Cristina Colombo, Rosa Maria Moresco, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2006
Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trialMichele Reni, Elisa Bonetto, Stefano Cordio, et al.
AIDS (London, England)|February 26, 2025
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimensMichele Bellomo, Nicola Gianotti, Hamid Hasson, et al.
International Journal of Cancer|July 29, 2011
Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignanciesVincenzo Spagnuolo, Laura Galli, Stefania Salpietro, et al.
AIDS (London, England)|March 27, 2026
Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio RegistryValeria Bono, Camilla Tincati, Matteo Augello, et al.
The New Microbiologica|August 24, 2016
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study)Nicola Gianotti, Laura Galli, Renato Maserati, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
The New Microbiologica|October 6, 2016
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR StudySilvia Nozza, Angela Rosa Pignataro, Laura Galli, et al.
AIDS (London, England)|July 25, 2014
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety resultsAntonella Castagna, Vincenzo Spagnuolo, Laura Galli, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013Antonella d'Arminio Monforte, Laura Galli, Sergio Lo Caputo, et al.
Psychopharmacology|March 13, 2003
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET studyCristina Messa, Cristina Colombo, Rosa Maria Moresco, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2006
Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trialMichele Reni, Elisa Bonetto, Stefano Cordio, et al.
AIDS (London, England)|February 26, 2025
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimensMichele Bellomo, Nicola Gianotti, Hamid Hasson, et al.
International Journal of Cancer|July 29, 2011
Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignanciesVincenzo Spagnuolo, Laura Galli, Stefania Salpietro, et al.
AIDS (London, England)|March 27, 2026
Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio RegistryValeria Bono, Camilla Tincati, Matteo Augello, et al.
The New Microbiologica|August 24, 2016
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study)Nicola Gianotti, Laura Galli, Renato Maserati, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
The New Microbiologica|October 6, 2016
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR StudySilvia Nozza, Angela Rosa Pignataro, Laura Galli, et al.
AIDS (London, England)|July 25, 2014
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety resultsAntonella Castagna, Vincenzo Spagnuolo, Laura Galli, et al.
Pageof 18